Compositions and methods for inhibition of the JAK pathway

Details for Australian Patent Application No. 2006254840 (hide)

Owner Rigel Pharmaceuticals, Inc.

Inventors Thota, Sambaiah; Taylor, Vanessa; Cooper, Robin; Li, Hui; Sran, Arvinder; Clough, Jeffrey; Tso, Kin; Singh, Rajinder; Keim, Holger; Argade, Ankush; Wong, Brian; Carroll, David; Bhamidipati, Somasekhar

Agent Griffith Hack

Pub. Number AU-B-2006254840

PCT Pub. Number WO2006/133426

Priority 60/776,636 24.02.06 US; 60/706,638 08.08.05 US; 60/689,032 08.06.05 US

Filing date 8 June 2006

Wipo publication date 14 December 2006

Acceptance publication date 2 August 2012

International Classifications

C07D 239/48 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 - Pyrimidines

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/133426 Priority application(s): WO2006/133426

2 August 2012 Application Accepted

  Published as AU-B-2006254840

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006254849-Data collection system and interface

2006254837-Methods and composition for diagnosis of neurological disorders in body fluids